Condition

Oxaliplatin clinical trials and research

As of November 12, 2026, Find a Trial lists 3 Oxaliplatin clinical trials that are recruiting, in China. By phase: Phase 2 (2), Phase 3 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.

Newest Oxaliplatin clinical trials

StudyPhaseWhereStatusRegistered
Comparing oxaliplatin plus S-1 versus docetaxel plus S-1 after surgery for stage III stomach cancer Phase 3 Shaoguan, Guandong and 4 other locations Recruiting Jan 26, 2026
Combination treatment for advanced pancreatic cancer Phase 2 Beijing, Beijing Municipality Recruiting May 8, 2024
Combining Lenvatinib, Tislelizumab, and TACE for Liver Cancer Treatment Phase 2 Hangzhou, Zhejiang Recruiting Jun 27, 2023

All recruiting trials (3)

Related topics

Adjuvant ChemotherapyAdvanced CancerCadonilimabCapecitabineDrug UseGastric Cancer (GC)Hepatocellular CarcinomaLenvatinibPancreatic AdenocarcinomaTACETislelizumabCadonilimabLenvatinibTislelizumab

Quick answers

How many Oxaliplatin clinical trials are recruiting right now?

3, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.

Where are these trials running?

All of them have sites in China. Each study page lists its sites and which ones are recruiting.

What phases are they in?

Phase 2: 2, Phase 3: 1. Trials with no phase listed are usually device, behavioural or observational studies.

How do I join one?

Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.

Find the studies that fit you

A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.

Describe your situation →

Last reviewed 2026-11-12 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.